NVS
Novartis AG
$150.80
+0.44 (+0.29%)
At close · Jul 15
Market Cap
$291.82B
Shares
1,908,091,965
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-06-11 | — | |
| 6-K | 2026-04-28 | 2026-03-31 | |
| 6-K | 2026-03-18 | — | |
| 6-K | 2026-02-04 | 2025-12-31 | |
| 20-F | 2026-02-04 | 2025-12-31 | |
| 6-K | 2026-02-04 | 2025-12-31 | |
| 6-K | 2025-11-25 | 2025-11-24 | |
| 6-K | 2025-11-20 | — | |
| 6-K | 2025-11-05 | — | |
| 6-K | 2025-10-28 | 2025-09-30 | |
| 6-K | 2025-10-27 | — | |
| 6-K | 2025-09-30 | — | |
| 6-K | 2025-08-11 | — | |
| 6-K | 2025-07-17 | — | |
| 6-K | 2025-07-17 | 2025-06-30 | |
| 6-K | 2025-06-02 | 2025-04-03 | |
| 6-K | 2025-04-29 | 2025-03-31 | |
| 6-K | 2025-04-03 | — | |
| 6-K | 2025-03-28 | — | |
| 6-K | 2025-01-31 | 2024-12-31 | |
| 20-F | 2025-01-31 | 2024-12-31 | |
| 6-K | 2025-01-31 | 2024-12-31 | |
| 6-K | 2024-12-30 | — | |
| 6-K | 2024-11-25 | 2024-11-21 | |
| 6-K | 2024-10-29 | 2024-09-30 | |
| 6-K | 2024-10-29 | — | |
| 6-K | 2024-09-18 | — | |
| 6-K | 2024-09-17 | — | |
| 6-K | 2024-08-08 | 2024-08-07 | |
| 6-K | 2024-07-18 | 2024-06-30 | |
| 6-K | 2024-04-23 | 2024-03-31 | |
| 6-K | 2024-01-31 | 2023-12-31 | |
| 6-K | 2024-01-31 | 2023-12-31 | |
| 20-F | 2024-01-31 | 2023-12-31 | |
| 6-K | 2024-01-08 | — | |
| 6-K | 2023-12-11 | — | |
| 6-K | 2023-12-06 | 2023-12-05 | |
| 6-K | 2023-11-28 | — | |
| 6-K | 2023-10-30 | — | |
| 6-K | 2023-10-24 | 2023-09-30 | |
| 6-K | 2023-10-04 | — | |
| 6-K | 2023-10-02 | — | |
| 6-K | 2023-09-05 | — | |
| 6-K | 2023-08-21 | 2023-08-18 | |
| 6-K | 2023-08-09 | — | |
| 6-K | 2023-07-18 | 2023-06-30 | |
| 6-K | 2023-07-10 | 2023-07-07 | |
| 6-K | 2023-06-12 | — | |
| 6-K | 2023-04-25 | 2023-03-31 | |
| 6-K | 2023-03-27 | — |
Showing 1–50 of 107 filings
Key facts
CIK
1114448
CUSIP
66987V109
13F (30d)
269 filings
253 filers
Visit website
Investor relations